Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jennifer A. Childress
Observed name:
Jennifer A Childress
Institution:
Moffitt Cancer Center
Observed institution:
Moffitt Cancer Center
OpenAlex ID:
A5114055059
Phase 1 dose-escalation, dose-expansion trial of intratumoral HER2- and HER3-primed dendritic cells injections for the treatment of early-stage TNBC and HR low positive breast cancer: DecipHER trial.
2023
·
Ricardo L Costa
, Jennifer A Childress
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Neoadjuvant therapy of HER2 directed conventional dendritic cell (DC1) intratumoral (IT) therapy plus weekly paclitaxel, trastuzumab, and pertuzumab in patients with HER-2 positive breast cancer: NATASHA trial.
2023
·
Hyo S. Han
, Ricardo L Costa
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Immunologic targeting of native and mutated ESR1 receptor for treatment of hormone receptor expressing metastatic breast cancer.
2025
·
Aixa Elena Soyano Muller
, Jennifer A. Childress
, et al.
·
Journal of Clinical Oncology
Phase I trial of capecitabine with cemiplimab in patients with hormone receptor–positive metastatic breast cancer.
2025
·
Aixa Elena Soyano Muller
, Aryanna Jordan
, et al.
·
Journal of Clinical Oncology
PDF
Show more works
View as search
Works count:
4
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type
